• Publications
  • Influence
Tularemia as a biological weapon: medical and public health management.
OBJECTIVE The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as aExpand
Botulinum toxin as a biological weapon: medical and public health management.
TLDR
People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months. Expand
Anthrax as a biological weapon, 2002: updated recommendations for management.
TLDR
This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the Anthrax Attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination. Expand
Biological warfare. A historical perspective.
TLDR
The history of biological warfare is difficult to assess because of a number of confounding factors, including difficulties in verification of alleged or attempted biological attacks, the use of allegations of biological attacks for propaganda purposes, and the incidence of naturally occurring endemic or epidemic diseases during hostilities. Expand
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
TLDR
Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection Control, home care, decontamination of the environment, and additional research needs. Expand
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
TLDR
The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. Expand
Clinical recognition and management of patients exposed to biological warfare agents.
TLDR
A primer on 10 classic biological warfare agents is provided to increase the likelihood of their being considered in a differential diagnosis and the impact of a terrorist attack greatly reduced. Expand
Clinical recognition and management of patients exposed to biological warfare agents.
TLDR
An updated primer on 11 classic BW and potential terrorist agents is provided to increase the likelihood of their being considered in a differential diagnosis. Expand
Hemorrhagic fever viruses as biological weapons: medical and public health management.
TLDR
Weapons disseminating a number of HFVs could cause an outbreak of an undifferentiated febrile illness 2 to 21 days later, associated with clinical manifestations that could include rash, hemorrhagic diathesis, and shock. Expand
Anthrax as a potential biological warfare agent.
TLDR
Human anthrax has been all but eradicated from the industrialized world, but the disease remains endemic in many areas of the world, and anthrax poses a threat as a mass casualty-producing weapon if used in a biological warfare capacity. Expand
...
1
2
3
4
5
...